Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Respiratory Syncytial Virus Infections × Suspensions × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urogenital Neoplasms 1 Small Cell Lung Carcinoma 1 Respiratory Syncytial Virus Infections 1 Prostatic Neoplasms 1 Lung Neoplasms 1 Genital Neoplasms, Male 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

remdesivir 1 Suspensions 1 Specimen Handling 1 Ribavirin 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06597916 2024-11-27

RSV Vaccination in Immunocompromised Patients.

Medical University of Vienna

Phase 2 Recruiting

Respiratory Syncytial Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡